Department of Pediatrics, Section of Gastroenterology, Hepatology and Nutrition, University of Colorado, Aurora, CO 80045, USA.
Neurogastroenterology and Motility Program, Digestive Health Institute, Children's Hospital Colorado, Aurora, CO 80045, USA.
Biomolecules. 2024 Mar 13;14(3):346. doi: 10.3390/biom14030346.
Phosphatase and tensin homolog (Pten) is a key regulator of cell proliferation and a potential target to stimulate postnatal enteric neuro- and/or gliogenesis. To investigate this, we generated two tamoxifen-inducible Cre recombinase murine models in which was conditionally ablated, (1) in glia (-expressing cells) and (2) in neurons (-expressing cells). Tamoxifen-treated adult (7-12 weeks of age; = 4-15) mice were given DSS to induce colitis, EdU to monitor cell proliferation, and were evaluated at two timepoints: (1) early (3-4 days post-DSS) and (2) late (3-4 weeks post-DSS). We investigated gut motility and evaluated the enteric nervous system. inhibition in -expressing cells elicited gliogenesis at baseline and post-DSS (early and late) in the colon, and neurogenesis post-DSS late in the proximal colon. They also exhibited an increased frequency of colonic migrating motor complexes (CMMC) and slower whole gut transit times. inhibition in -expressing cells did not induce enteric neuro- or gliogenesis, and no alterations were detected in CMMC or whole gut transit times when compared to the control at baseline or post-DSS (early and late). Our results merit further research into modulation where increased glia and/or slower intestinal transit times are desired (e.g., short-bowel syndrome and rapid-transit disorders).
磷酸酶和张力蛋白同源物 (Pten) 是细胞增殖的关键调节因子,也是刺激出生后肠神经和/或神经胶质发生的潜在靶点。为了研究这一点,我们生成了两种他莫昔芬诱导的 Cre 重组酶小鼠模型,其中 基因在条件性缺失,(1)在神经胶质细胞(表达细胞)中,(2)在神经元(表达细胞)中。用他莫昔芬处理成年(7-12 周龄;n = 4-15)小鼠,给予 DSS 诱导结肠炎,用 EdU 监测细胞增殖,并在两个时间点进行评估:(1)早期(DSS 后 3-4 天)和(2)晚期(DSS 后 3-4 周)。我们研究了肠道蠕动,并评估了肠神经系统。在基线和 DSS 后(早期和晚期)的结肠中,在 -表达细胞中抑制 会引起神经胶质发生,在近端结肠中会引起神经发生。它们还表现出更高频率的结肠移行性运动复合波(CMMC)和更慢的全肠道通过时间。在 -表达细胞中抑制 不会诱导肠神经或神经胶质发生,与基线或 DSS 后(早期和晚期)的对照相比,在 CMMC 或全肠道通过时间方面没有发现任何变化。我们的结果值得进一步研究 调节,其中需要增加神经胶质细胞和/或减缓肠道通过时间(例如,短肠综合征和快速通过障碍)。